Featured

Event Description

Antigenix Therapeutics is a growing biotech company headquartered in Princeton, NJ, dedicated to giving cancer patients more hope and more choices. The company, which is hiring, is developing antibody-based therapies that precisely target cancer cells to push the boundaries of what is possible in cancer treatment. With deep expertise in antibody-drug conjugate development, translational medicine, and biotech venture creation, Antigenix Therapeutics is advancing a new generation of monoclonal antibody therapies against novel, tumor-specific targets. By harnessing the unique biology of these proteins, the company is working to create safer, more effective treatment options for patients facing the greatest unmet needs. Dowdy Jackson, PhD is the CSO at Antigenix Therapeutics, and brings 28 years of experience guiding research teams at major pharmaceutical companies and medium to smaller biotech companies.

Click here to see slides.

Event Description

This workshop will equip PhD students, postdocs, and faculty with practical strategies to strengthen grant and fellowship applications in today’s evolving funding environment. Participants will learn how to frame proposals to align with shifting federal and foundation priorities, craft compelling research narratives, and position their work for maximum impact and competitiveness.

Representatives from Lewis-Burke Associates and the Rutgers Foundation will provide an overview of the current federal research landscape, including key opportunities for fellowships and early-career awards, as well as recent and anticipated policy changes affecting international trainees.

Finally, we will highlight broader trends to watch, including changes in review criteria, increased emphasis on translational impact and data rigor, and evolving expectations around collaboration and research direction. Participants will do a hands-on exercise to frame their research to align with these trends and leave with clear, actionable guidance for navigating funding opportunities and adapting their proposals to a rapidly changing environment.

IN-PERSON ONLY

Event Description

Join this event to find out about the job search process. Recruiters can be some of the most useful advocates during your search and there is no cost to you to use them since the company that hires you will pay them.  A staffing agency can:

*Coach candidates through entire process

*Help with resume formatting/writing

*Access to jobs that aren’t otherwise posted/skill marketing

*Interview coaching-especially in today’s virtual world

*Assist with salary discussions/negotiating offers and job packages

In-person or Zoom options

Click here to see contact information.

Event Description

Medical affairs is a unique organization within a life science company that focuses on the communications between the company and medical professionals, healthcare providers, and patients. Roles within Medical Affairs include Medical Science Liaison, Medical Information, Pharmacovigliance, Regulatory Affairs etc… Come hear from a panel of PhD level individuals who are in medical affairs to learn about their career path and find out about the Board Certification in Medical Affairs.

Click here to see speaker information.

Event Description

Premal Shah's career has spanned both academia and industry, he spent over six years as an Assistant Professor of Genetics at Rutgers University, where he was a member of the Human Genetics Institute of New Jersey and led research on the dynamics and evolution of gene regulation and protein synthesis. Since transitioning to industry in 2022, he has held Director-level roles at Ananke Therapeutics and a stealth-mode biotech firm, where he led computational biology, RNA design, and target discovery efforts to advance the next generation of RNA-based therapeutics. SanegeneBio is a global biotech with a singular vision: Best-in-class RNAi medicines. They are focused on discovering and developing best-in-class genetic medicines for obesity, cardiometabolic, and autoimmune diseases using RNA interference (RNAi) technology. Their proprietary technology platform, LEAD™ (Ligand and Enhancer Assisted Delivery), enables tissue-specific silencing of disease-driving genes in the liver, adipose tissue, muscle, and immune cells—achieved through safe, infrequent subcutaneous dosing. Throughout his career, he has built and led interdisciplinary teams of molecular biologists, computer scientists, and statisticians, integrating high-throughput genomics with bioinformatics and computational approaches. 

Click here to see slides.